Bio-Rad Laboratoriesvs.Hologic
BIO vs HOLX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Hologic is about 2.1× larger than Bio-Rad Laboratories by market cap; Hologic trades at the lower P/E (31.2 vs 47.1); year to date, Hologic leads (+2.0% vs −2.3%).
Side by side
| BIO | HOLX | |
|---|---|---|
| Market cap | $8B | $17B |
| Price | $296.11 | — |
| Today | −0.4% | — |
| Return YTD | −2.3% | +2.0% |
| Return 1Y | +13.9% | −3.5% |
| P/E | 47.1 | 31.2 |
| P/S | 3.1 | 4.1 |
| P/B | 1.2 | 3.2 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Bio-Rad LaboratoriesBIO
American manufacturer of products for clinical diagnostics and life science research — including blood typing and droplet digital PCR.
Full BIO profile →HologicHOLX
American medical technology company focused on women's health — diagnostics, mammography (imaging) and surgery.
Full HOLX profile →More comparisons in Diagnostics
See where BIO and HOLX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →